Janux Therapeutics (JANX) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to $2.6 million.
- Janux Therapeutics' Other Non-Current Assets fell 694.3% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 694.3%. This contributed to the annual value of $2.9 million for FY2024, which is 1494.62% up from last year.
- Per Janux Therapeutics' latest filing, its Other Non-Current Assets stood at $2.6 million for Q3 2025, which was down 694.3% from $2.7 million recorded in Q2 2025.
- Over the past 5 years, Janux Therapeutics' Other Non-Current Assets peaked at $2.9 million during Q4 2024, and registered a low of $140000.0 during Q3 2021.
- In the last 5 years, Janux Therapeutics' Other Non-Current Assets had a median value of $2.4 million in 2023 and averaged $2.0 million.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 92357.14% in 2022, then crashed by 694.3% in 2025.
- Over the past 5 years, Janux Therapeutics' Other Non-Current Assets (Quarter) stood at $816000.0 in 2021, then skyrocketed by 70.34% to $1.4 million in 2022, then surged by 80.5% to $2.5 million in 2023, then grew by 14.95% to $2.9 million in 2024, then dropped by 8.91% to $2.6 million in 2025.
- Its Other Non-Current Assets stands at $2.6 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.8 million for Q1 2025.